Cardinal Health, Inc. Hits New 52-Week High of $233.19

Cardinal Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 233.19 on March 2, 2026. This achievement underscores the company's strong performance over the past year, with a remarkable increase of 132.58%, significantly outpacing the S&P 500's growth of 17.36% during the same period. As a large-cap player in the retailing industry, Cardinal Health boasts a market capitalization of USD 62,465 million. The company's price-to-earnings (P/E) ratio stands at 25.00, reflecting its valuation in the market. However, it is noteworthy that the company currently has a dividend yield of 0.00%, indicating that it does not distribute dividends to shareholders. In terms of financial health, Cardinal Health's debt-to-equity ratio is reported at -2.17, and its return on equity is at -69.93%. The stock's price-to-book ratio is also negative at -21.66, suggesting challenges in asset valuation. Overall, the recent price movement highlights Cardinal Health's notable performance in the retailing sector.